News

As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are reporting. In very rare cases they can be deadly. Here’s what to know.
The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are ...
A 69-year-old woman was referred to the retina service for abnormal posterior segment findings.The patient’s medical history ...
Getting into the exercise habit was also important since one day, most people on Ozempic or Wegovy will stop taking it – putting themselves at risk of putting the weight back on if they were not ...
Another area where this ICH guideline interfaces with prior ischemic stroke guidelines is the challenging area of antithrombotic agent use in patients after ICH who are at risk for both recurrent ICH ...
Background/aims To assess the performance of a deep learning classifier for differentiation of glaucomatous optic neuropathy (GON) from compressive optic neuropathy (CON) based on ganglion cell–inner ...
Geneva: The World Health Organization (WHO) has issued a global safety alert highlighting the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use ...
NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.
WHO is alerting health-care professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicines—Ozempic, ...